Unlike traditional cell therapies that require harvesting and re-engineering a patient's cells outside the body, Sail's platform is designed to reprogram immune cells directly inside the body, an approach the companies say could make CAR T manufacturing simpler and more scalable while delivering durable, potentially curative results
These are research-context interests, not validated clinical outcomes
The mechanisms that drive this association include systemic inflammation, endothelial dysfunction, oxidative stress, hypertension, and metabolic dysfunction
the scalp serum is water-based and fast-absorbing, no sticky residue, no oily flattening
What changes is the documentation requirement
doi: 10.20471/acc.2019.58.02.13